Literature DB >> 32583714

Exosomes transfer miRNAs from cell-to-cell to inhibit autophagy during infection with Crohn's disease-associated adherent-invasive E. coli.

Anaïs Larabi1, Guillaume Dalmasso1, Julien Delmas1,2, Nicolas Barnich1, Hang Thi Thu Nguyen1.   

Abstract

Adherent-invasive E. coli (AIEC), which abnormally colonize the intestinal mucosa of Crohn's disease (CD) patients, are able to adhere to and invade intestinal epithelial cells (IECs), survive and replicate within macrophages and induce a pro-inflammatory response. AIEC infection of IECs induces secretion of exosomes that increase AIEC replication in exosome-receiving IECs and macrophages. Here, we investigated the mechanism underlying the increased AIEC replication in cells receiving exosomes from AIEC-infected cells. Exosomes released by uninfected human intestinal epithelial T84 cells (Exo-uninfected) or by T84 cells infected with the clinical AIEC LF82 strain (Exo-LF82), the nonpathogenic E. coli K12 strain (Exo-K12) or the commensal E. coli HS strain (Exo-HS) were purified and used to stimulate T84 cells. Stimulation of T84 cells with Exo-LF82 inhibited autophagy compared with Exo-uninfected, Exo-K12 and Exo-HS. qRT-PCR analysis revealed increased levels of miR-30c and miR-130a in Exo-LF82 compared to Exo-uninfected, Exo-K12 and Exo-HS. These miRNAs were transferred via exosomes to recipient cells, in which they targeted and inhibited ATG5 and ATG16L1 expression and thereby autophagy response, thus favoring AIEC intracellular replication. Inhibition of these miRNAs in exosome-donor cells infected with AIEC LF82 abolished the increase in miR-30c and miR-130a levels in the released Exo-LF82 and in Exo-LF82-receiving cells, thus suppressing the inhibitory effect of Exo-LF82 on ATG5 and ATG16L1 expression and on autophagy-mediated AIEC clearance in Exo-LF82-receiving cells. Our study shows that upon AIEC infection, IECs secrete exosomes that can transfer specific miRNAs to recipient IECs, inhibiting autophagy-mediated clearance of intracellular AIEC.

Entities:  

Keywords:  AIEC; Crohn’s disease; autophagy; exosomes; miRNA

Year:  2020        PMID: 32583714      PMCID: PMC7524154          DOI: 10.1080/19490976.2020.1771985

Source DB:  PubMed          Journal:  Gut Microbes        ISSN: 1949-0976


  42 in total

1.  A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease.

Authors:  Patrick Brest; Pierre Lapaquette; Mouloud Souidi; Kevin Lebrigand; Annabelle Cesaro; Valérie Vouret-Craviari; Bernard Mari; Pascal Barbry; Jean-François Mosnier; Xavier Hébuterne; Annick Harel-Bellan; Baharia Mograbi; Arlette Darfeuille-Michaud; Paul Hofman
Journal:  Nat Genet       Date:  2011-01-30       Impact factor: 38.330

Review 2.  Adherent-invasive Escherichia coli in inflammatory bowel disease.

Authors:  Carolina Palmela; Caroline Chevarin; Zhilu Xu; Joana Torres; Gwladys Sevrin; Robert Hirten; Nicolas Barnich; Siew C Ng; Jean-Frederic Colombel
Journal:  Gut       Date:  2017-11-15       Impact factor: 23.059

3.  Adherent invasive Escherichia coli strains from patients with Crohn's disease survive and replicate within macrophages without inducing host cell death.

Authors:  A L Glasser; J Boudeau; N Barnich; M H Perruchot; J F Colombel; A Darfeuille-Michaud
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Lung-Derived Exosomal miR-483-3p Regulates the Innate Immune Response to Influenza Virus Infection.

Authors:  Tadashi Maemura; Satoshi Fukuyama; Yukihiko Sugita; Tiago J S Lopes; Tomomi Nakao; Takeshi Noda; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2018-04-11       Impact factor: 5.226

5.  Serum exosomes of chronic gastritis patients infected with Helicobacter pylori mediate IL-1α expression via IL-6 trans-signalling in gastric epithelial cells.

Authors:  Y Chen; X Wang; Y Yu; Y Xiao; J Huang; Z Yao; X Chen; T Zhou; P Li; C Xu
Journal:  Clin Exp Immunol       Date:  2018-10-01       Impact factor: 4.330

6.  Exosome-delivered microRNAs modulate the inflammatory response to endotoxin.

Authors:  Margaret Alexander; Ruozhen Hu; Marah C Runtsch; Dominique A Kagele; Timothy L Mosbruger; Tanya Tolmachova; Miguel C Seabra; June L Round; Diane M Ward; Ryan M O'Connell
Journal:  Nat Commun       Date:  2015-06-18       Impact factor: 14.919

7.  Exosome-mediated miR-146a transfer suppresses type I interferon response and facilitates EV71 infection.

Authors:  Yuxuan Fu; Li Zhang; Fang Zhang; Ting Tang; Qi Zhou; Chunhong Feng; Yu Jin; Zhiwei Wu
Journal:  PLoS Pathog       Date:  2017-09-14       Impact factor: 6.823

8.  Crohn's Disease-Associated Adherent-Invasive Escherichia coli Manipulate Host Autophagy by Impairing SUMOylation.

Authors:  Guillaume Dalmasso; Hang T T Nguyen; Tiphanie Faïs; Sébastien Massier; Nicolas Barnich; Julien Delmas; Richard Bonnet
Journal:  Cells       Date:  2019-01-09       Impact factor: 6.600

9.  Crohn's disease adherent-invasive Escherichia coli colonize and induce strong gut inflammation in transgenic mice expressing human CEACAM.

Authors:  Frédéric A Carvalho; Nicolas Barnich; Adeline Sivignon; Claude Darcha; Carlos H F Chan; Clifford P Stanners; Arlette Darfeuille-Michaud
Journal:  J Exp Med       Date:  2009-09-08       Impact factor: 14.307

10.  Exosomes as nanocarriers for systemic delivery of the Helicobacter pylori virulence factor CagA.

Authors:  Asako Shimoda; Koji Ueda; Shin Nishiumi; Naoko Murata-Kamiya; Sada-Atsu Mukai; Shin-ichi Sawada; Takeshi Azuma; Masanori Hatakeyama; Kazunari Akiyoshi
Journal:  Sci Rep       Date:  2016-01-07       Impact factor: 4.379

View more
  9 in total

Review 1.  MicroRNA and Gut Microbiota: Tiny but Mighty-Novel Insights into Their Cross-talk in Inflammatory Bowel Disease Pathogenesis and Therapeutics.

Authors:  Maite Casado-Bedmar; Emilie Viennois
Journal:  J Crohns Colitis       Date:  2022-07-14       Impact factor: 10.020

Review 2.  Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models.

Authors:  Kanika Suri; Jason A Bubier; Michael V Wiles; Leonard D Shultz; Mansoor M Amiji; Vishnu Hosur
Journal:  Cells       Date:  2021-08-26       Impact factor: 7.666

3.  Global trends in research on miRNA-microbiome interaction from 2011 to 2021: A bibliometric analysis.

Authors:  Xiang-Yun Yan; Jun-Peng Yao; Yan-Qiu Li; Wei Zhang; Meng-Han Xi; Min Chen; Ying Li
Journal:  Front Pharmacol       Date:  2022-08-30       Impact factor: 5.988

Review 4.  Impact of the Exposome on the Epigenome in Inflammatory Bowel Disease Patients and Animal Models.

Authors:  Sophie Vieujean; Bénédicte Caron; Vincent Haghnejad; Jean-Yves Jouzeau; Patrick Netter; Anne-Charlotte Heba; Ndeye Coumba Ndiaye; David Moulin; Guillermo Barreto; Silvio Danese; Laurent Peyrin-Biroulet
Journal:  Int J Mol Sci       Date:  2022-07-09       Impact factor: 6.208

5.  Yersiniabactin Siderophore of Crohn's Disease-Associated Adherent-Invasive Escherichia coli Is Involved in Autophagy Activation in Host Cells.

Authors:  Guillaume Dalmasso; Hang Thi Thu Nguyen; Tiphanie Faïs; Sébastien Massier; Caroline Chevarin; Emilie Vazeille; Nicolas Barnich; Julien Delmas; Richard Bonnet
Journal:  Int J Mol Sci       Date:  2021-03-29       Impact factor: 5.923

Review 6.  Organ-on-a-Chip for Studying Gut-Brain Interaction Mediated by Extracellular Vesicles in the Gut Microenvironment.

Authors:  Min-Hyeok Kim; Danny van Noort; Jong Hwan Sung; Sungsu Park
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

Review 7.  Regulation of autophagy by miRNAs in human diseases.

Authors:  Sounak Ghosh Roy
Journal:  Nucleus (Calcutta)       Date:  2021-10-16

Review 8.  Understanding microRNAs in the Context of Infection to Find New Treatments against Human Bacterial Pathogens.

Authors:  Álvaro Mourenza; Blanca Lorente-Torres; Elena Durante; Jesús Llano-Verdeja; Jesús F Aparicio; Arsenio Fernández-López; José A Gil; Luis M Mateos; Michal Letek
Journal:  Antibiotics (Basel)       Date:  2022-03-08

Review 9.  No small matter: emerging roles for exosomal miRNAs in the immune system.

Authors:  Kaylyn M Bauer; June L Round; Ryan M O'Connell
Journal:  FEBS J       Date:  2021-06-19       Impact factor: 5.622

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.